key: cord-0948338-nr3i1wha
authors: Jain, Amit; Doyle, D. John; Mangal, Ramesh
title: “Mosaic Perfusion Pattern” on Dual-Energy CT in COVID-19 Pneumonia: Pulmonary Vasoplegia or Vasoconstriction?
date: 2020-09-10
journal: Radiol Cardiothorac Imaging
DOI: 10.1148/ryct.2020200433
sha: 7af446a7db960158111ed66d8a67e2b04b1fc27c
doc_id: 948338
cord_uid: nr3i1wha

nan

Editor:

Finding dilated sub-segmental vessels on dual-energy CT (DECT), Lang et al (1) proposed inflammatory-mediated impaired hypoxic pulmonary vasoconstriction (HPV) with overactive regional vasodilation to explain COVID-19 hypoxemia. However, this was not associated with increased pulmonary blood volume (PBV) in consolidated areas; instead, most (96%) patients had decreased peripheral perfusion corresponding to peripheral lung opacities and only one-third demonstrated a halo of increased perfusion surrounding peripheral opacities. If HPV loss occurs in consolidated regions, PBV should have increased, producing hyperaemia rather than oligemia.

We instead propose an Ang-II-mediated, non-immune, non-inflammatory mechanism to explain the mosaic perfusion pattern.

Ang-II-AT1R pathway overactivity, producing heterogenous small vessel vasoconstriction (2) and recruitment of segmental/sub-segmental vessels with relatively less vasoconstriction, causing regional over-perfusion, reduced diffusion-capacity, increased shunt and hypoxia, even in the absence of radiologically evident lesions. Where precapillary constriction is intense (due to high local concentration of Ang-II), pulmonary blood flow would decrease, reducing perfusion even in normal lung or may produce wedge-shaped areas of pulmonary deficit on DECT (3). In areas of ineffective constriction due to lower concentrations of Ang-II capillary filtration-pressure would increase, resulting in capillary stress-failure and hydrostatic interstitial-edema with patchy ground-glass opacities (GGOs) on CT. Disruption of the alveolocapillary membrane develops, with SARS-CoV-2 directly infecting endothelial cells. Endothelialitis with intra-capillary fibrinmicrothrombi blocks alveolar capillaries and further decreases perfusion within the areas of I n p r e s s halo of increased perfusion surrounding regions of consolidation. Thus, in COVID-19 pneumonia as the GGOs worsens to consolidation, oligemia or hyperemia in the area of consolidation is largely determined by the balance between the endothelialitis-mediated capillary obstruction (in consolidation regions) versus Ang-II-mediated regional vasoconstriction (in healthy lung regions) (3, 4) .

Our theory is supported by high incidence of raised PVR and RV dysfunction in early COVID-19 disease (5) and reports of lung perfusion deficits that do not overlap with GGOs or consolidation and are not associated with major vessel occlusion (3) 

We read the letter "Mosaic Perfusion Pattern" on Dual-Energy CT in COVID-19 Pneumonia:

Pulmonary Vasoplegia or Vasoconstriction" with great interest. The Ang-II-mediated, nonimmune, non-inflammatory mechanism proposed by the authors is well aligned with our imaging observations. First, the authors suggested that the recruitment of segmental/sub-segmental vessels via Ang-II-AT1R pathway may lead to regional over-perfusion. We noted increased regional perfusion toward areas of diseased lung on DECT imaging, described as a "hyperemic halo" in 36% of cases. (1) Furthermore, we described unusual dilation of vessels proximal to and within pulmonary opacities, and dilated vessels along the pleura and fissures. Consistent with the authors' proposed mechanisms, our radiologic observations are suggestive of abnormal vessel recruitment and abnormal shunting of blood toward areas of poor gas exchange, possibly explaining the pronounced hypoxemia seen in a subset of patients with COVID-19 pneumonia.

Second, the authors suggest endothelialitis with intra-capillary fibrin-microthrombi as well as capillary stress-failure as a possible explanation for the ground-glass opacity and consolidation seen in COVID-19 pneumonia. This again is compatible with our vascular findings suggesting that a pronounced underlying vascular process may be at play. Ground-glass opacity may in part be a result of capillary leakage from endothelial injury and increased hydrostatic pressure from Finally, the authors broach an interesting point regarding the high incidence of elevated PVR and RV dysfunction in COVID-19 patients. The vascular abnormalities reported in our paper, including dilated vessels and mosaic attenuation and perfusion, were not limited to areas of diseased lung. This suggests that shunting and alterations in pulmonary perfusion is diffuse and that the cumulative effect may lead to elevated PVR and RV dysfunction as the authors reported.

We appreciate the authors' letter and think their proposed underlying mechanisms are congruent with our findings and may help explain development of severe hypoxemia in a subset of patients with COVID-19 pneumonia. Finally, these thrombogenic and direct vascular/endothelial abnormalities may also contribute to multiorgan involvement in COVID-19 cases.

Pulmonary Vascular Manifestations of COVID-19 Pneumonia

Stages or phenotypes? A critical look at COVID-19 pathophysiology

Gulcin Telli Dizman, Selin Ardali Duzgun et al. Lung and Kidney Perfusion Deficits Diagnosed by Dual-Energy Computed Tomography

PREPRINT (Version 1) available at Research Square

Pulmonary vascular manifestations of COVID-19 pneumonia

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19

Vascular and perfusion abnormalities on dual energy CT: a possible explanation for COVID-19 related hypoxemia?

Pulmonary Vascular Pathology in Covid-19